| Conference scene: miniaturisation - micro scale bioprocess development. | |
| | |
MedLine Citation:
|
PMID: 21174552 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The Miniaturisation - Micro Scale Bioprocess Development conference organized by Euroscicon hosted 44 delegates from the UK, Germany and Switzerland. The aim of the meeting was to highlight the recent technologies used in high-throughput bioprocess development, ranging from the selection of clones through to the analysis of the final product and formulation. Expert speakers discussed the development and use of up-to-date miniaturization technologies and the regulatory hurdles that must be overcome to expedite a wider industrial uptake. The meeting was chaired by Gary Lye (University College London, UK). Lye gave a detailed introduction to the meeting, ending with a talk and a summation at the close of the conference. |
| | |
Authors:
|
Lesley Margaret Chiverton |
Publication Detail:
|
Type: Congresses; News |
Journal Detail:
|
Title: Immunotherapy Volume: 3 ISSN: 1750-7448 ISO Abbreviation: Immunotherapy Publication Date: 2011 Jan |
Date Detail:
|
Created Date: 2010-12-22 Completed Date: 2011-04-11 Revised Date: 2011-04-28 |
Medline Journal Info:
|
Nlm Unique ID: 101485158 Medline TA: Immunotherapy Country: England |
Other Details:
|
Languages: eng Pagination: 13-6 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Bioreactors Biotechnology* / instrumentation, methods Cell Culture Techniques Chromatography Gene Therapy / methods High-Throughput Screening Assays / instrumentation* Humans Immunoglobulin Fragments / metabolism Miniaturization / instrumentation* Nanotechnology / instrumentation, methods |
| Chemical | |
Reg. No./Substance:
|
0/Immunoglobulin Fragments |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Stereotactic body radiation therapy for adrenal metastases: a retrospective review of a noninvasive ...
Next Document: Immunologic therapy targeting metastatic melanoma: allovectin-7.